- Filed
- Apr 10, 2023 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2022 · Apr 7, 2023 | 248.99M sh |
| Stock Redeemed | Q3 2022 · Sep 30, 2022 | 82.26M sh |
| Operating Cash Flow | Q3 2022 · Sep 30, 2022 | −$98.77M |
| Operating Cash Flow | Q3 2022 · Sep 30, 2021 | −$21.8M |
| Short Term Investments | Q3 2022 · Sep 30, 2022 | $156K |
| Short Term Investments | Q3 2022 · Dec 31, 2021 | $178K |
| Cash And Equivalents | Q3 2022 · Sep 30, 2022 | $20.19M |
| Cash And Equivalents | Q3 2022 · Dec 31, 2021 | $86.7M |
| Stockholders Equity | Q3 2022 · Sep 30, 2022 | $123.36M |
| Stockholders Equity | Q3 2022 · Dec 31, 2021 | $113.42M |
| Current Liabilities | Q3 2022 · Sep 30, 2022 | $32.7M |
| Current Liabilities | Q3 2022 · Dec 31, 2021 | $70.09M |
| Total Liabilities | Q3 2022 · Sep 30, 2022 | $57.73M |
| Total Liabilities | Q3 2022 · Dec 31, 2021 | $271.46M |
| Current Assets | Q3 2022 · Sep 30, 2022 | $34.36M |
| Current Assets | Q3 2022 · Dec 31, 2021 | $203.74M |
| Total Assets | Q3 2022 · Sep 30, 2022 | $117.21M |
| Total Assets | Q3 2022 · Dec 31, 2021 | $405.14M |
| Eps Diluted | Q3 2022 · Sep 30, 2022 | −$0.40 |
| Eps Diluted | Q3 2022 · Sep 30, 2022 | −$1.51 |
| Eps Diluted restated | Q3 2022 · Sep 30, 2021 | −$7.60 |
| Eps Diluted restated | Q3 2022 · Sep 30, 2021 | −$18.54 |
| Sga Expense | Q3 2022 · Sep 30, 2022 | $19.47M |
| Sga Expense | Q3 2022 · Sep 30, 2022 | $75.06M |
| Sga Expense restated | Q3 2022 · Sep 30, 2021 | $25.61M |
| Sga Expense restated | Q3 2022 · Sep 30, 2021 | $42.3M |
| Net Income | Q3 2022 · Sep 30, 2022 | −$98.98M |
| Net Income | Q3 2022 · Sep 30, 2022 | −$326M |
| Net Income | Q3 2022 · Sep 30, 2021 | −$542.46M |
| Net Income | Q3 2022 · Sep 30, 2021 | −$788.6M |
| Operating Income | Q3 2022 · Sep 30, 2022 | −$173.12M |
| Operating Income | Q3 2022 · Sep 30, 2022 | −$229.75M |
| Operating Income restated | Q3 2022 · Sep 30, 2021 | −$25.48M |
| Operating Income restated | Q3 2022 · Sep 30, 2021 | −$41.36M |
| Gross Profit | Q3 2022 · Sep 30, 2022 | −$1.24M |
| Gross Profit | Q3 2022 · Sep 30, 2022 | −$1.82M |
| Gross Profit restated | Q3 2022 · Sep 30, 2021 | $129.67K |
| Gross Profit restated | Q3 2022 · Sep 30, 2021 | $935.17K |
| Cost Of Revenue | Q3 2022 · Sep 30, 2022 | $6.8M |
| Cost Of Revenue | Q3 2022 · Sep 30, 2022 | $25.52M |
| Cost Of Revenue restated | Q3 2022 · Sep 30, 2021 | $99.33K |
| Cost Of Revenue restated | Q3 2022 · Sep 30, 2021 | $786.46K |
| Revenue | Q3 2022 · Sep 30, 2022 | $5.56M |
| Revenue | Q3 2022 · Sep 30, 2022 | $23.71M |
| Revenue restated | Q3 2022 · Sep 30, 2021 | $229K |
| Revenue restated | Q3 2022 · Sep 30, 2021 | $1.72M |